INS and acromegaly: Nine patients were excluded from the primary analysis because of study discontinuation (n = 2; both with Cushing’s disease, randomized to insulin) or receipt of rescue medication (n = 7 [Cushing’s disease, n = 5; acromegaly, n = 2]) within 8 weeks of randomization.